Literature DB >> 1415976

Does hypothermia protect against the development of hepatitis in paracetamol overdose?

R Block1, J A Jankowski, P Lacoux, C R Pennington.   

Abstract

A 24-year-old female presented in hospital following self-poisoning with a dose of greater than 30 g of paracetamol (acetaminophen), taken both as co-proxamol (dextropropoxyphene and paracetamol) and paracetamol. She arrived in hospital more than 18 h after ingestion of the drug. On admission, she was profoundly hypothermic, with a rectal temperature of 19 degrees C. Her paracetamol level was 943 mumol.l-1 which, when related to the time of ingestion, implied a very high risk of hepatocellular damage as well as fulminant liver failure, even if she was treated with the antioxidant n-acetylcysteine. The patient's condition was stabilised by initial resuscitation with fluids, vasoactive drugs, and active rewarming. N-acetylcysteine therapy was begun promptly. This patient's liver function tests remained entirely normal in spite of the delay in presentation and she made a rapid and complete recovery. This remarkable clinical course indicates a possible role for therapeutically induced hypothermia in the management of severe paracetamol overdose, particularly in the group of patients who seek medical attention some hours after ingestion of the drug and who therefore remain at high risk, despite treatment with n-acetylcysteine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415976     DOI: 10.1111/j.1365-2044.1992.tb03258.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  3 in total

1.  Liver failure induced by paracetamol.

Authors:  R Block
Journal:  BMJ       Date:  1993-02-13

2.  Concomitant overdosing of other drugs in patients with paracetamol poisoning.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

3.  Acetaminophen (Paracetamol) Induces Hypothermia During Acute Cold Stress.

Authors:  Josh Foster; Alexis R Mauger; Andrew Govus; David Hewson; Lee Taylor
Journal:  Clin Drug Investig       Date:  2017-11       Impact factor: 2.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.